Sagimet Biosciences Inc.

AI Score

0

Unlock

3.45
-0.26 (-7.13%)
At close: Mar 03, 2025, 3:59 PM
3.51
1.68%
After-hours: Mar 03, 2025, 05:31 PM EST

Sagimet Biosciences Income Statement

Year FY23 FY22 FY21 FY20 FY19
Revenue 2M n/a n/a n/a n/a
Cost of Revenue n/a 130K 134K 124K 88K
Gross Profit 2M -130K -134K -124K -88K
Operating Income -30.74M -31.05M -23.72M -11.4M -14.25M
Interest Income 2.86M 553K 26K 30K 128K
Pretax Income -27.88M -30.5M -24.44M -11.37M -14.26M
Net Income -27.88M -30.5M -24.44M -11.37M -14.26M
Selling & General & Admin 12.96M 6.14M 4.38M 3.22M 5.86M
Research & Development 19.78M 24.92M 19.34M 8.18M 8.39M
Other Expenses n/a 3K -749K n/a -73K
Operating Expenses 32.74M 31.05M 23.72M 11.4M 14.25M
Interest Expense n/a n/a n/a n/a 64K
Selling & Marketing Expenses n/a n/a n/a n/a n/a
Cost & Expenses 32.74M 31.05M 23.72M 11.4M 14.25M
Income Tax n/a -31.61M -23.75M -176.3K -9K
Shares Outstanding (Basic) 10.46M 22.17M 22.17M 22.17M 22.17M
Shares Outstanding (Diluted) 10.46M 22.17M 22.17M 22.17M 22.17M
EPS (Basic) -2.66 -1.38 -1.1 -0.51 -0.64
EPS (Diluted) -2.66 -1.38 -1.1 -0.51 -0.64
EBITDA -30.74M -30.37M -24.31M -11.25M -14.11M
Depreciation & Amortization n/a 130K 134K 124K 88K